10.01.2011
- French drugmaker Sanofi-Aventis and Genzyme Corp are discussing options for significantly raising Sanofi's bid for the the U.S. biotech company to about $80 per share, the Wall...
07.01.2011
- Monsanto, the world's largest seed company, said on Thursday that a line-up of new biotech seed products have the company well positioned for future growth. St. Louis, Mo.-based...
21.12.2010
- Novozymes, the world's top industrial enzymes maker, is buying U.S. based EMD/Merck Crop BioScience for $275 million from Merck KGaA , boosting its presence in the fast-growing...
21.12.2010
- Genzyme argued that its experimental multiple sclerosis treatment will garner far higher sales than Sanofi-Aventis is projecting, as it aims to wrest a significantly higher bid...
15.12.2010
- French drugmaker Sanofi-Aventis is in talks to invest in Hadasit Bio-Holdings, the Israeli biotech holding company said on Tuesday. Hadasit said the potential investment would be...
14.12.2010
- Sanofi-Aventis named Elias Zerhouni as its new head of research and development as the French drugmaker reshapes its drug portfolio to offset sales losses from patent expiries...
13.12.2010
- Sanofi-Aventis has extended its snubbed $18.5 billion cash bid for U.S. biotech group Genzyme by six weeks, buying the French drugmaker time to persuade its reluctant target to...
10.12.2010
- Northern Exposure - When global companies expand into new countries, these firms often co-locate in local areas that are a business hub for other companies in the same industry...
08.12.2010
- U.S. healthcare group Johnson & Johnson made a long-awaited €1.75 billion bid for Crucell on Wednesday, shrugging off the Dutch biotech company's recent problems with vaccine...